Group One Trading’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$658 Sell
100
-1,100
-92% -$5.1K ﹤0.01% 7225
2026
Q2
$6.3K Sell
1,200
-500
-29% -$2.52K ﹤0.01% 6626
2026
Q1
$6.32K Sell
1,700
-300
-15% -$2.07K ﹤0.01% 6604
2025
Q4
$16.4K Sell
2,000
-1,300
-39% -$9.6K ﹤0.01% 6506
2025
Q3
$24.3K Buy
3,300
+2,300
+230% +$17.4K ﹤0.01% 6551
2025
Q2
$8.12K Sell
1,000
-2,500
-71% -$16.9K ﹤0.01% 6840
2025
Q1
$24.6K Buy
3,500
+1,500
+75% +$9.32K ﹤0.01% 5678
2024
Q4
$14.9K Sell
2,000
-1,900
-49% -$12.1K ﹤0.01% 5886
2024
Q3
$19.2K Sell
3,900
-5,300
-58% -$27.7K ﹤0.01% 5250
2024
Q2
$47.2K Buy
9,200
+1,500
+19% +$8.88K ﹤0.01% 4559
2024
Q1
$40.9K Buy
7,700
+5,200
+208% +$37.2K ﹤0.01% 4878
2023
Q4
$15.5K Sell
2,500
-11,700
-82% -$81.2K ﹤0.01% 5932
2023
Q3
$107K Sell
14,200
-32,100
-69% -$293K ﹤0.01% 4388
2023
Q2
$448K Buy
46,300
+45,900
+11,475% +$280K ﹤0.01% 3131
2023
Q1
$1.51K Buy
+400
New +$2.23K ﹤0.01% 6680
2022
Q4
– Sell
-800
Closed -$71K – 7706
2022
Q3
$71K Buy
+800
New +$8.14K ﹤0.01% 5102
2013
Q4
– Sell
-2,000
Closed -$24K – 5383
2013
Q3
$24K Sell
2,000
-6,200
-76% -$86.5K ﹤0.01% 4057
2013
Q2
$108K Buy
+8,200
New +$113K ﹤0.01% 2745

Other funds holding LFCR

Group One Trading's LFCR Position: Q3 2026 in Review

Group One Trading increased its Lifecore Biomedical (LFCR) stake by 93% in Q3 2026, buying an estimated $13K and bringing the position to 5,798 shares worth $38.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5436.

Group One Trading first reported a position in LFCR in Q2 2013 and has held it in 13 quarters since. The position peaked at $113K in Q3 2023. 105 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.

  • Group One Trading held 5,798 shares of Lifecore Biomedical worth $38.2K as of Q3 2026.
  • Group One Trading bought 2,800 Lifecore Biomedical shares in Q3 2026, an estimated $13K.
  • Lifecore Biomedical made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #5436 holding.
  • Group One Trading first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 13 quarters since.
  • Group One Trading's Lifecore Biomedical position peaked at $113K in Q3 2023.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.